ArticleFrontiers in immunology2021

The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis.

Balazs Odler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.